Genetic Engineering & Biotechnology News

JAN15 2018

Genetic Engineering & Biotechnology News (GEN) is the world's most widely read biotech publication. It provides the R&D community with critical information on the tools, technologies, and trends that drive the biotech industry.

Issue link: https://gen.epubxp.com/i/923111

Contents of this Issue

Navigation

Page 26 of 29

For more information, visit our website (GENengnews.com), click on New Products, and search through our comprehensive new products database. New Products Genetic Engineering & Biotechnology News | GENengnews.com | JANUARY 15, 2018 | 25 People Clinical OMICs extends GEN's comprehensive coverage to the clinic by focusing on the application of revolutionary molecular technologies in medical practice. Topics covered include personalized and precision medicine, next-gen sequencing, bioinformatics, reimbursement, and bioethics. To see past issues, recent news, and subscribe, go to: clinicalomics.com GEN'S ePUB Molecular Diagnostics in Personalized Medicine 3D Printing and Additive Manufacturing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17 Advanced Analytical . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14 BD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15 BMG Labtech . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13 Clinical OMICs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25 GEN/ACD webinar . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23 GEN/Carterra webinar . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21 GEN/Maxcyte webinar . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 GEN/MilliporeSigma supplement . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7 Human Gene Therapy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20 Integra Biosciences . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 Novo Nordisk Pharmatech A/S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19 OriGene . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 PerkinElmer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28 Roche Diagnostics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Cover Tip The CRISPR Journal . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 Advertiser Index Reprints Karen Ballen 914-740-2194 reprints@GENengnews.com GEN offers reprints of individual articles — in print- ed or electronic form — to increase awareness of your product or company. Order today! Onxeo established a scientific advisory board, consisting of Tomas Lindahl, M.D.; Marie Dutreix, Ph.D.; Penny Jeggo, Ph.D.; Yves Pommier, M.D., Ph.D.; Robert Bristow, M.D., Ph.D.; Sebastian Amigorena, Ph.D.; and Josef Jiricny, Ph.D. Oncolytics Biotech formed a scientific advisory board that includes Mattine Piccart, M.D., Ph.D.; Alex Prat, M.D., Ph.D.; and Padmanee Sharma, M.D., Ph.D. Immunomet appointed Briggs W. Morrison, M.D., and Paul Lammers, M.D., to its board of directors. Context Therapeutics hired Scott Applebaum as president and Richard Morris as executive vice president and CFO. Goldfinch Bio hired Anthony Johnson, M.D., as president and CEO, and Michael Broxson as chief business and operating officer. The Medicines Company elected Fredric N. Eshelman, PharmD., as executive chairman, and Geno Germano as a mem- ber of its board of directors. BioAlta hired James Allison, Ph.D., and Padmanee Sharma, M.D., Ph.D., as scientific advisors. Nosopharm appointed Gilles Alberici, Ph.D., PharmD., and Marie-Paule Richard, D.M., to its supervisory board. Jennifer Cook is the new CEO at GRAIL. Clinical Genomics welcomed Roy Davis as senior advisor and board member. Intella promoted John Leonard, M.D., to president and CEO. Christina Waters, Ph.D., is the new senior vice president, rare diseases, at WuXi NextCODE. Acceleron elected Karen Smith, M.D., Ph.D., to its board of directors. IRX Therapeutics appointed Luba Greenwood to its board of directors. Jazz Pharmaceuticals hired Daniel N. Swisher Jr. as president and CEO. Turnstone Biologics appointed Mike Burgess, MBChB, Ph.D., as president of R&D. Laura Shawver, Ph.D., is the new president and CEO of Synthorx. Paul J. Hastings will resume the position of chairman, president, and CEO of OncoMed. Ian Mills, BMBCh, D.M., is the new CMO at Outpost Medicine. TM3 Therapeutics appointed Peter Van Vlasselaer, Ph.D., as chairman of the board of directors. Merrimack elected George Demetri, M.D., to its board of directors. J. Craig Venter, Ph.D., was reappointed as CEO of Human Longevity. Tracon Pharmaceuticals appointed Brian Daniels, M.D., to its scientific advisory board. Matthew D. Bayley, M.D., is now on the board of directors at Aevi Genomic Medicine Dayton Misfeldt is the Interim CEO of Sunesis Pharmaceuticals. Steve Shallcross is serving as the Interim CEO of Synthetic Biologics. OncoSec promoted Christopher G. Twitty, Ph.D., to CSO. Purigen Biosystems hired Barney Saunders, Ph.D., as CEO. Richard Kenney, M.D., is the acting CMO at TapImmune. Zhen Su, M.D., is the new CMO at EMD Serono. Glen J. Weiss, M.D., is the new CMO at Circulogene. Ann Barbier, M.D., Ph.D., is the new CMO at Translate Bio. Dr. Barbier was vice president, clinical develop- ment, rare diseases, at Agios Pharmaceuticals. Prior to that, she held several posi- tions at Shire, including global clinical development lead. Earlier in her career, Dr. Barbier worked at Envivo, Johnson & Johnson, and Aventis. Profile Illumina appointed Gary S. Guthart, Ph.D., to its board of directors. Dr. Guthart is the president and CEO of Intuitive Surgical. Before that, he was part of the core team for com- puter-enhanced surgery at the Stanford Research Institute. Profile Gamida Cell welcomed Julian Adams, Ph.D., as CEO and chairman of the board. Dr. Adams is the former president and CSO of Clal Biotechnolo- gies. Prior to that, he served as president of R&D at Infinity Pharmaceuticals. And earlier in his career, Dr. Adams was vice president, drug discovery and development, at Millennium Pharmaceuticals. Profile Subscribe Subscribe to GEN Highlights eNewsletter All the news you need to know, delivered to your inbox. Daily. GENengnews.com/ subscription

Articles in this issue

Links on this page

Archives of this issue

view archives of Genetic Engineering & Biotechnology News - JAN15 2018